iofina plc (AIM: IOF) is a vertically integrated Company that specializes in the exploration and production of iodine and the manufacturing of specialty chemical derivatives. With operations in Kentucky and Oklahoma, Iofina’s strategy is to identify, develop, build, own and operate iodine extraction plants based on the Company’s WET® IOsorb® technology. The Company produces iodine from brine solutions produced in oil and gas fields at its multiple IOsorb® plants in Oklahoma. Iofina integrates the iodine into an array of specialty iodine derivatives, which are created and sold through Iofina Chemical to diverse global markets. Additionally, Iofina sells iodine globally and also produces other non-iodine specialty chemicals.
Iofina Resources
Iofina Resources develops, builds, owns and operates iodine extraction plants using Iofina’s WET® IOsorb® technology. Iofina currently operates five producing IOsorb® plants in Oklahoma and is consistently using technology and innovation to improve and expand its operations.
Iofina Chemical
Iofina Chemical has manufactured high quality halogen speciality chemicals derived from raw iodine, as well as non-iodine based products. Iofina Chemical will be celebrating its 40th anniversary in 2023 as a preeminent halogen-based specialty chemicals company.
Plant Operating at Expected Rate Iofina plc, specialists in the exploration and production of iodine and manufacturers of specialty chemical …
Signed Agreement for IO#10 and Q3 2023 Update Iofina plc, specialists in the exploration and production of iodine and manufacturers …
Iofina plc, specialists in the exploration and production of iodine and manufacturers of specialty chemical products, is pleased to announce …
H1 Update and Updated Loan Facilities Iofina plc (AIM:IOF), specialists in the exploration and production of iodine and manufacturers of …
Iodine producer Iofina plc shas today announced that the Company’s IO#9 IOsorb® plant has become the company’s sixth plant now …
AIM listed Iodine producers Iofina plc, has announced another year of record revenues, driven by sustained demand and a strong …
P&L | 31 Dec 2022 US$~000 | 31 Dec 2021 US$~000 |
---|---|---|
Revenue | 42,198 | 39,039 |
Cost of sales | (26,369) | (28,307) |
Gross Profit | 15,829 | 10,732 |
Profit before tax | 10,030 | 5,120 |
Balance Sheet | 31 Dec 2022 US$~000 | 31 Dec 2021 US$~000 |
---|---|---|
Cash | 5,927 | 5,262 |
Total assets | 52,706 | 44,445 |
Total liabilities | 14,734 | 7,289 |
“Iodine deficiency is the biggest cause of brain damage in the world… The mineral is essential for growth and development and is especially important for pregnant women. Iofina is an AIM-listed business based in Colorado, which produces iodine and turns it into compounds sold around the world. The shares are 23.25p and should increase substantially over the next few years.”
This study identifies the increase in spending by the pharmaceutical industry as one of the prime reasons driving the iodine market growth during the next few years. Also, the recycling of iodine and the flourishing medical tourism industry across the globe will lead to sizable demand in the market.